BOARD OF DIRECTORS CAMERON PIRON Chairman and Director Cameron Piron is an industry-recognized leader and innovator in image-guided surgery. Prior to co-founding Synaptive Medical, Cameron was president and co-founder of Sentinelle Medical, a medical device company that developed and manufactured advanced MRI-based breast imaging technologies. Sentinelle grew to over 200 employees and over $20 million in revenues before being acquired by Hologic, Inc. in 2010. Cameron studied systems design engineering at the University of Waterloo, followed by a graduate degree at the University of Toronto in medical biophysics. His awards include the Ontario Premier’s Catalyst Award for Best Young Innovator in 2008; the University of Waterloo’s Alumni Achievement medal in 2009 for leading Sentinelle Medical in researching and manufacturing leading- edge MRI technologies that allow physicians to diagnose breast cancer and other medical conditions faster and more accurately; being named to Canada’s Top 40 Under 40™ list in 2009, which was established by Caldwell Partners and celebrates the achievements of young Canadians in the private, public and non-profit sectors; and being the first Canadian ever to win R&D Magazine’s Innovator of the Year award in 2008. In 2015, Cameron was named one of Fast Company’s Most Creative People. He chairs Synaptive’s Board of Directors and heads the company’s executive committee. MKT-00612 Rev. A
5
Embed
BOARD OF DIRECTORS - Synaptive Medical · He chairs Synaptive’s Board of Directors and heads the company’s executive committee. MKT-00612 Rev. ... Butland is the managing partner
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
B O A R D O F D I R E C T O R S
C A M E R O N P I R O N
Chairman and Director
Cameron Piron is an industry-recognized leader and innovator in
image-guided surgery. Prior to co-founding Synaptive Medical,
Cameron was president and co-founder of Sentinelle Medical, a
medical device company that developed and manufactured advanced
MRI-based breast imaging technologies. Sentinelle grew to over 200
employees and over $20 million in revenues before being acquired by
Hologic, Inc. in 2010. Cameron studied systems design engineering
at the University of Waterloo, followed by a graduate degree at the
University of Toronto in medical biophysics. His awards include the
Ontario Premier’s Catalyst Award for Best Young Innovator in 2008;
the University of Waterloo’s Alumni Achievement medal in 2009 for
leading Sentinelle Medical in researching and manufacturing leading-
edge MRI technologies that allow physicians to diagnose breast
cancer and other medical conditions faster and more accurately;
being named to Canada’s Top 40 Under 40™ list in 2009, which was
established by Caldwell Partners and celebrates the achievements of
young Canadians in the private, public and non-profit sectors; and
being the first Canadian ever to win R&D Magazine’s Innovator of
the Year award in 2008. In 2015, Cameron was named one of Fast
Company’s Most Creative People. He chairs Synaptive’s Board of
Directors and heads the company’s executive committee.
MKT-00612 Rev. A
R I C H A R D B U T L A N D
Director
Richard Butland is the managing partner of Kite Capital, a growth
orientated private investment firm. Prior to establishing Kite Capital,
Richard spent 15 years at Goldman Sachs. He joined Goldman
Sachs in 2000 in the UK Advisory Group and was named managing
director in 2006. He ran the UK M&A Advisory business in 2007
and subsequently moved to the Merchant Banking Division to head
its private equity activities in the UK and Energy across Europe.
Richard worked at IBJ Schroder Bank and PricewaterhouseCoopers
prior to Goldman Sachs. He earned a bachelor’s degree in finance
from Victoria University of Wellington and qualified as a chartered
accountant.
D AV I D C A L U O R I
Director
David Caluori joined General Atlantic as a principal in 2014 where
he focuses on investments in the healthcare sector. Prior to joining
General Atlantic, David was with Welsh, Carson, Anderson & Stowe,
where he focused exclusively on investments in the healthcare sector.
He began his career in healthcare investment banking at Piper Jaffray
and Jefferies. David is on the board of Oak Street Health and received
a bachelor of arts in economics from Brown University.
D AV I D G A L L O P
Director
David Gallop has 15 years of experience in medical software
development. He graduated with a B.A.Sc. in Electrical Engineering
from McGill University in 2000 and began his career at eFilm Medical,
remaining on board for two years following its acquisition by Merge
Healthcare. David then joined Sentinelle Medical and was one of the
primary architects of its Aegis Breast diagnostic software. Following
Sentinelle’s acquisition by Hologic, Inc., David co-founded Synaptive
Medical, and is now focused on the architecture and development of
Synaptive’s BrightMatter suite of software products.
MKT-00612 Rev. A
D O U G J A N Z E N
Director
Doug Janzen brings over 20 years of experience in life sciences
to Synaptive’s Board of Directors with leadership experience in
corporate finance, business development, and management. During
his nine-year tenure at Cardiome Pharma (NASDAQ: CRME), Doug held
a series of positions including chief financial officer (2003 to 2005),
president and chief business officer (2005 to 2009), and president
and CEO (2009 to 2012). During this time, he raised over C$300
million from investors, completed over C$1 billion in licensing deals,
and led a partnership with Merck to bring Cardiome’s lead product,
Brinavess, through to clinical approval and marketing in Europe.
Doug is currently co-founder and managing director of NorthView
Ventures, chairman and CEO of Aequus Pharmaceuticals, and serves
on the Boards of Aequus Pharmaceuticals, Alabaster Technologies,
Abcellera (chairman), Ico Therapeutics, Perimeter Medical Imaging, and
Renaissance Biosciences. Prior to Cardiome, Doug was an investment
banker with Cormark Securities, acting as managing director of life
sciences, and has completed over C$1 billion in equity financing for
Canadian biotech companies. Doug is past chair of LifeSciences BC,
has served as a director with Biotech Canada and is a past winner of
Business in Vancouver’s “Top 40 Under 40 Award.”
W E S H O D G E S
Director
Wes Hodges graduated from the University of Toronto’s Engineering
Science program in 2003. In 2001, he began his career in medical
imaging at eFilm Medical. Following its acquisition by Merge
Healthcare in 2002, Wes formed Sentinelle Medical’s software
division in 2005, developing its 3D Aegis Breast diagnostic and
interventional platform. A few years following Sentinelle’s acquisition
by Hologic, Inc. in 2010, Wes co founded Synaptive Medical where
he focuses on developing a unifying software framework across its
various products.
MKT-00612 Rev. A
A N D R E W P R O Z E S
Director
Andrew Prozes currently serves on the boards of Transunion, Cott